1,018
Participants
Start Date
November 30, 2014
Primary Completion Date
November 30, 2018
Study Completion Date
November 30, 2018
enzalutamide
oral
Numakunai
Aichi
Akita
Aomori
Chiba
Ehime
Fukui
Fukuoka
Fukushima
Gifu
Gunma
Hiroshima
Hokkaido
Hyōgo
Ibaraki
Ishikawa
Kagawa
Kagoshima
Kanagawa
Kochi
Kumamoto
Kyoto
Mie
Miyagi
Miyazaki
Nagano
Nagasaki
Nara
Niigata
Okayama
Okinawa
Osaka
Ōita
Saga
Saitama
Shiga
Shimane
Shizuoka
Tochigi
Tokushima
Tokyo
Tottori
Toyama
Wakayama
Yamagata
Yamaguchi
Yamanashi
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Astellas Pharma Inc
INDUSTRY